(MedPage Today) — More than a third of older men with lower urinary tract symptoms (LUTS) derived little or no benefit from an alpha-blocker and might be candidates for “deprescribing,” a small, randomized study suggested.
During active treatment…
(MedPage Today) — More than a third of older men with lower urinary tract symptoms (LUTS) derived little or no benefit from an alpha-blocker and might be candidates for “deprescribing,” a small, randomized study suggested.
During active treatment…